FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306932784> ?p ?o ?g. }

• W4306932784 endingPage "114850" @default.
• W4306932784 startingPage "114850" @default.
• W4306932784 abstract "In this work, a large set of betulinic acid derivatives modified with various aromatic substituents at the position C-3 were prepared via Suzuki-Myiaura cross-coupling. All compounds were tested for their in vitro cytotoxic activity in 8 cancer and 2 healthy cell lines. Derivatives 6h, 6i, and 6o had the lowest IC50 in the CCRF-CEM cell line (0.69-4.0 μM) and had high selectivity. In addition, 6h and 6i also showed significant activity in daunorubicin-resistant CEM and taxol-resistant K562 cell lines; therefore, they were selected for the evaluation of the mechanism of action. First, the effect of 6h, 6i, and 6o on cell death induction was studied. To our surprise, we have not detected almost any apoptotic cells, even following a long-time exposure of CCRF-CEM cells to the compounds. On the other hand, a dramatic cell number decrease was observed, proportional to the time of the compound's exposure. Based on this data it was concluded that the effect of compounds is cytostatic rather than cytotoxic, which was further confirmed by subsequent studies of the impact of 6h, 6i, and 6o on the cell cycle. Detailed cell cycle analysis revealed a block in the G1 phase accompanied by reduced expression of phosphorylated forms of the RB protein as well as cyclin A protein. Evaluation of the pharmacological properties of the most promising compounds revealed their high stability in the presence of phosphate buffer, human plasma, and microsomes and limited permeability determined using permeability through artificial membrane (PAMPA) and cell permeability assay: Caco-2 and MDCK-MDR1 cell lines. Compounds 6h, 6i, and 6o were selected for further drug development; their cytostatic effect may be advantageous in this process since we expect fewer non-specific interactions and toxicity than in highly cytotoxic compounds. In addition, the activity of 6h and 6i against resistant CEM-DNR and K562-TAX leukemic cell lines makes them promising as a possible future alternative to currently used therapies." @default.
• W4306932784 created "2022-10-21" @default.
• W4306932784 creator A5005249211 @default.
• W4306932784 creator A5021455739 @default.
• W4306932784 creator A5024903730 @default.
• W4306932784 creator A5025125941 @default.
• W4306932784 creator A5028402946 @default.
• W4306932784 creator A5035166463 @default.
• W4306932784 creator A5037983418 @default.
• W4306932784 creator A5046720279 @default.
• W4306932784 creator A5074219212 @default.
• W4306932784 creator A5085106624 @default.
• W4306932784 date "2022-12-01" @default.
• W4306932784 modified "2023-09-29" @default.
• W4306932784 title "Lupane derivatives containing various aryl substituents in the position 3 have selective cytostatic effect in leukemic cancer cells including resistant phenotypes" @default.
• W4306932784 cites W1170929448 @default.
• W4306932784 cites W1450513492 @default.
• W4306932784 cites W1764303255 @default.
• W4306932784 cites W1987789354 @default.
• W4306932784 cites W2003569626 @default.
• W4306932784 cites W2014493202 @default.
• W4306932784 cites W2017074079 @default.
• W4306932784 cites W2034988225 @default.
• W4306932784 cites W2038975953 @default.
• W4306932784 cites W2046827775 @default.
• W4306932784 cites W2056814754 @default.
• W4306932784 cites W2073101936 @default.
• W4306932784 cites W2084375116 @default.
• W4306932784 cites W2095193361 @default.
• W4306932784 cites W2096130774 @default.
• W4306932784 cites W2102803288 @default.
• W4306932784 cites W2138511186 @default.
• W4306932784 cites W2173340258 @default.
• W4306932784 cites W2203240887 @default.
• W4306932784 cites W2250820623 @default.
• W4306932784 cites W2294220942 @default.
• W4306932784 cites W2317083400 @default.
• W4306932784 cites W2331086861 @default.
• W4306932784 cites W2335617625 @default.
• W4306932784 cites W2340851024 @default.
• W4306932784 cites W2418899779 @default.
• W4306932784 cites W2519017866 @default.
• W4306932784 cites W2591575767 @default.
• W4306932784 cites W2609186521 @default.
• W4306932784 cites W2735375550 @default.
• W4306932784 cites W2782321209 @default.
• W4306932784 cites W2783199813 @default.
• W4306932784 cites W2790220533 @default.
• W4306932784 cites W2791785968 @default.
• W4306932784 cites W2800860028 @default.
• W4306932784 cites W2800917659 @default.
• W4306932784 cites W2809317141 @default.
• W4306932784 cites W2946974563 @default.
• W4306932784 cites W2971080678 @default.
• W4306932784 cites W2975283146 @default.
• W4306932784 cites W2981477066 @default.
• W4306932784 cites W3049342150 @default.
• W4306932784 cites W3122989212 @default.
• W4306932784 cites W3178326138 @default.
• W4306932784 cites W4211113755 @default.
• W4306932784 cites W4211134609 @default.
• W4306932784 cites W4211185947 @default.
• W4306932784 cites W4251301530 @default.
• W4306932784 cites W4296894932 @default.
• W4306932784 doi "https://doi.org/10.1016/j.ejmech.2022.114850" @default.
• W4306932784 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36283179" @default.
• W4306932784 hasPublicationYear "2022" @default.
• W4306932784 type Work @default.
• W4306932784 citedByCount "0" @default.
• W4306932784 crossrefType "journal-article" @default.
• W4306932784 hasAuthorship W4306932784A5005249211 @default.
• W4306932784 hasAuthorship W4306932784A5021455739 @default.
• W4306932784 hasAuthorship W4306932784A5024903730 @default.
• W4306932784 hasAuthorship W4306932784A5025125941 @default.
• W4306932784 hasAuthorship W4306932784A5028402946 @default.
• W4306932784 hasAuthorship W4306932784A5035166463 @default.
• W4306932784 hasAuthorship W4306932784A5037983418 @default.
• W4306932784 hasAuthorship W4306932784A5046720279 @default.
• W4306932784 hasAuthorship W4306932784A5074219212 @default.
• W4306932784 hasAuthorship W4306932784A5085106624 @default.
• W4306932784 hasConcept C105696609 @default.
• W4306932784 hasConcept C109316439 @default.
• W4306932784 hasConcept C121608353 @default.
• W4306932784 hasConcept C126322002 @default.
• W4306932784 hasConcept C154317977 @default.
• W4306932784 hasConcept C178790620 @default.
• W4306932784 hasConcept C185592680 @default.
• W4306932784 hasConcept C190283241 @default.
• W4306932784 hasConcept C202751555 @default.
• W4306932784 hasConcept C2777829905 @default.
• W4306932784 hasConcept C2778461978 @default.
• W4306932784 hasConcept C2780263894 @default.
• W4306932784 hasConcept C2781021840 @default.
• W4306932784 hasConcept C2781076698 @default.
• W4306932784 hasConcept C29537977 @default.
• W4306932784 hasConcept C2992270614 @default.
• W4306932784 hasConcept C41625074 @default.
• W4306932784 hasConcept C54355233 @default.

• next